NCT05109143View on ClinicalTrials.gov

Efficacy of Rectal Indomethacin in Prevention of Post-operative Pancreatitis After Pancreaticoduodenectomy

NACompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

October 17, 2020

Primary Completion Date

April 30, 2022

Study Completion Date

May 31, 2022

Conditions
Pancreatoduodenectomy
Interventions
DRUG

Indomethacin suppository

100mg Indomethacin Suppository administered at the time of Induction

OTHER

Standard Medical Treatment

Standard Medical Treatment

Trial Locations (1)

110070

Institute of Liver & Biliary Sciences, New Delhi

All Listed Sponsors
lead

Institute of Liver and Biliary Sciences, India

OTHER

NCT05109143 - Efficacy of Rectal Indomethacin in Prevention of Post-operative Pancreatitis After Pancreaticoduodenectomy | Biotech Hunter | Biotech Hunter